50458-611 : Invega Hafyera 700 mg/3.5ml Intramuscular Injection, Suspension, Extended Release


NDC: 50458-611
Labeler: Janssen Pharmaceuticals, Inc
Product Type: Human Prescription Drug
Drug Name: Invega Hafyera
Dosage Form: Intramuscular Injection, Suspension, Extended Release
Application #: NDA207946
Rev. Date: 


NDC Package Codes:

  • 50458-611-01: 1 SYRINGE IN 1 CARTON (50458‑611‑01) > 3.5 ML IN 1 SYRINGE

Active Ingredients:

  • Paliperidone Palmitate

Dosage Strength:

  • 1092 mg/3.5mL

Pharmaceutical Classes:

  • Atypical Antipsychotic [EPC]

Related Products:

Based on records with the same trade name.
  • 50458-612 Invega Hafyera 1000 mg/5ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50458-611 QR Code

< Prev: 50458-609Next: 50458-612 >

Related Discussions:

Paliperidone Palmitate
Does IM injection Paliperidone Palmitate (Invega Sustenna) lose potency or become unsafe if it has been stored in far ab... 2 replies
Paliperidone withdrawal. Will the receptors be unblocked?
I've been taking the Xeplion (Paliperidone) injection for about a year now. This drug blocks the serotonin and dopam...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.